Alteration of Cellular Reduction Potential Will Change (64)Cu-ATSM Signal With or Without Hypoxia

Therapies targeting reductive/oxidative (redox) metabolism hold potential in cancers resistant to chemotherapy and radiation. A redox imaging marker would help identify cancers susceptible to redox-directed therapies. Copper(II)-diacetyl-bis(4-methylthiosemicarbazonato) (Cu-ATSM) is a PET tracer dev...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nucl Med
Autors principals: Floberg, John M., Wang, Lingjue, Bandara, Nilantha, Rashmi, Ramachandran, Mpoy, Cedric, Garbow, Joel R., Rogers, Buck E., Patti, Gary J., Schwarz, Julie K.
Format: Artigo
Idioma:Inglês
Publicat: Society of Nuclear Medicine 2020
Matèries:
Molecular Imaging
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067520/
https://ncbi.nlm.nih.gov/pubmed/31586008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.230805
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars